drugset / Trial / NCT04120597
Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Polycystic ovary syndrome is the most common endocrine and metabolic disorder in gynecology. Traditional Chinese medicine has a good clinical effect in the treatment of PCOS. We intend to conduct this trial in strict accordance with the requirements of evidence-based medicine, through a multi-center, randomized, controlled study, using a double-blind, randomized, placebo-controlled study design method to clarify that Zishen Qingre Lishi Huayu Recipe restores spontaneous ovulation in PCOS patients. The overall efficacy of improving the characteristics of Kaohsiung and glucose and lipid metabolism is optimal, and high-level evidence-based evidence is obtained to form a diagnosis and treatment plan for promotion.
Timeline
- Start
- 2019-12-23
- Primary completion
- 2021-08-20
- Completion
- 2021-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zishen Qingre Lishi Huayu Granules | Unknown | — | — |